Nonsurgical Periodontal Therapy on Banded First Molars

January 25, 2018 updated by: Dr.Jaideep Mahendra, Meenakshi Ammal Dental College and Hospital

Effect on Nonsurgical Periodontal Therapy on First Molars Banded for Fixed Orthodontic Treatment

The aim of this study was to evaluate the effect of nonsurgical periodontal therapy on first molars banded for fixed orthodontic treatment.

Study Overview

Detailed Description

A total of 30 patients who were about to undergo fixed orthodontic therapy were selected and divided into two groups.

Group A comprised of 15 patients who were treated with routine full-mouth supragingival scaling and subgingival scaling only around all banded first molars.

Group B comprised of 15 patients who were treated with full-mouth supragingival scaling and subgingival scaling only around all banded first molars followed by irrigation with 0.2% chlorhexidine gluconate solution (Trade name: HEXIDINE), an antiseptic - antiplaque agent. Treatment for both the groups was performed at 3rd month, 6th month and 9th month.

Parameters such as radiographic evidence of alveolar crestal bone level, gingival index, probing pocket depth and clinical attachment level around the banded first molars and full-mouth plaque index were recorded as a change from baseline to 12th month. The differences between the values were assessed and sent for statistical analysis.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Phase 1

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 25 years (ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Both male and female patients within the age group 16 to 25 years.
  2. Patients diagnosed with malocclusion undergoing fixed orthodontic treatment having banded first molars.
  3. Systemically healthy patients.

Exclusion Criteria:

  1. Congenital malformations in the oral cavity.
  2. Patients who had undergone periodontal therapy within the previous 6 months.
  3. Patients using removable orthodontic appliances.
  4. Patients who were administered antibiotics or other systemic or topical antimicrobial agents.
  5. Smokers.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
PLACEBO_COMPARATOR: Supragingival and subgingival scaling
Supragingival and subgingival scaling group comprised of 15 orthodontic patients treated with routine full-mouth supragingival scaling and subgingival scaling only around all banded first molars. Parameters such as radiographic evidence of alveolar crestal bone level, gingival index, probing pocket depth and clinical attachment level around the banded first molars and full-mouth plaque index were recorded as a change from baseline to 12th month.
Control group comprised of 15 patients who were treated with routine full-mouth supragingival scaling.
Other Names:
  • Oral prophylaxis
Test group comprised of 15 patients who were treated with subgingival scaling only around all banded first molars.
Other Names:
  • Deep scaling
ACTIVE_COMPARATOR: Subgingival irrigation
Subgingival irrigation group comprised of 15 orthodontic patients treated with full-mouth supragingival scaling and subgingival scaling only around all banded first molars followed by irrigation with 0.2% chlorhexidine gluconate solution (Trade name: HEXIDINE), an antiseptic - antiplaque agent. Parameters such as radiographic evidence of alveolar crestal bone level, gingival index, probing pocket depth and clinical attachment level around the banded first molars and full-mouth plaque index were recorded as a change from baseline to 12th month.
Control group comprised of 15 patients who were treated with routine full-mouth supragingival scaling.
Other Names:
  • Oral prophylaxis
Test group comprised of 15 patients who were treated with subgingival scaling only around all banded first molars.
Other Names:
  • Deep scaling
Test group comprised of 15 patients who were treated with subgingival irrigation only around all banded first molars with 0.2% chlorhexidine gluconate solution (Trade name: HEXIDINE), an antiseptic - antiplaque agent.
Other Names:
  • Chemical plaque control

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline radiographic evidence of alveolar crestal bone level at 12th month
Time Frame: Baseline to 12th month
Radiographic evidence of alveolar crestal bone level was measured around each banded first molar
Baseline to 12th month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline plaque index at 12th month
Time Frame: Baseline to 12 month
Full-mouth plaque index measurements were carried out at four sites around each tooth (mesiobuccal, buccal, distobuccal and lingual).
Baseline to 12 month
Change from baseline gingival index at 12th month
Time Frame: Baseline to 12th month
The measurements were carried out around all the banded first molars at four sites (mesiobuccal, buccal, distobuccal and lingual).
Baseline to 12th month
Change from baseline probing pocket depth at 12th month
Time Frame: Baseline to 12th month
The probing pocket depth was measured clinically using Williams periodontal probe at six sites (mesiobuccal, buccal, distobuccal, mesiolingual, distolingual and lingual) of each banded first molar.
Baseline to 12th month
Change from baseline clinical attachment level at 12th month
Time Frame: Baseline to 12th month
Clinical attachment level (CAL) was measured as the distance between a fixed point on the crown such as cementoenamel junction to the base of the pocket.
Baseline to 12th month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nashra Kareem, BDS, Meenakshi Ammal Dental college and hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

April 1, 2016

Primary Completion (ACTUAL)

August 30, 2017

Study Completion (ACTUAL)

November 29, 2017

Study Registration Dates

First Submitted

January 4, 2018

First Submitted That Met QC Criteria

January 18, 2018

First Posted (ACTUAL)

January 25, 2018

Study Record Updates

Last Update Posted (ACTUAL)

January 26, 2018

Last Update Submitted That Met QC Criteria

January 25, 2018

Last Verified

January 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • MADC/IRB-IX/2016/153

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Periodontitis

Clinical Trials on Full-mouth supragingival scaling

3
Subscribe